aTyr Pharma (LIFE) Misses Q4 EPS by 1c
aTyr Pharma (NASDAQ: LIFE) reported Q4 EPS of ($0.25), $0.01 worse than the analyst estimate of ($0.24).
For earnings history and earnings-related data on aTyr Pharma (LIFE) click here.
aTyr Pharma (NASDAQ: LIFE) reported Q4 EPS of ($0.25), $0.01 worse than the analyst estimate of ($0.24).
For earnings history and earnings-related data on aTyr Pharma (LIFE) click here.